It is unclear whether germline carriers of the p.(Asp92Gly) SDHD mutation are at elevated risk of HNPGL and despite no tumours having been reported in the family, it is the opinion of their clinicians that surveillance was advisable and is ongoing. Here, SDHD is linked to neoplasm.